Pharmacological Evaluation of Humanized Anti-Epidermal Growth Factor Receptor, Monoclonal Antibody h-R3, in Patients With Advanced Epithelial-Derived Cancer-Reference-Cited by-同舟云学术

Pharmacological Evaluation of Humanized Anti-Epidermal Growth Factor Receptor, Monoclonal Antibody h-R3, in Patients With Advanced Epithelial-Derived Cancer

Published:2003-03 Issue:2 Volume:26 Page:139-148
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:Journal of Immunotherapy

Author:

Crombet Tania,Torres Leonel,Neninger Elia,Catalá Mauricio,Solano María E.,Perera Alejandro,Torres Olga,Iznaga Normando,Torres Franz,Pérez Rolando,Lage Agustín

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference55 articles.

1. EGFR and cancer prognosis

2. Intratumoral infusion of the monoclonal antibody, mAb 425, against the epidermal-growth-factor receptor in patients with advanced malignant glioma

3. A comparison of epidermal growth factor receptor (EGFR) and c-erbB-2 oncogene expression in head and neck squamous cell carcinomas

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concurrent chemoradiotherapy combined with nimotuzumab in stage III–IVa nasopharyngeal carcinoma: a retrospective analysis;Journal of Cancer Research and Clinical Oncology;2022-10-27

2. Nimotuzumab Increases the Recovery Rate of Severe and Critical COVID-19 Patients: Evaluation in the Real-World Scenario;Frontiers in Public Health;2022-07-22

3. The efficacy and safety of neoadjuvant nimotuzumab for gastric cancer;Medicine;2021-12-17

4. Nimotuzumab therapy in the treatment of pediatric central nervous system tumors: single-center experience;Naunyn-Schmiedeberg's Archives of Pharmacology;2021-06-21

5. Modeling and Molecular Dynamic Simulation of F(ab′)2 Fragment of Nimotuzumab for Lung Cancer Diagnostics;Bioinformatics and Biology Insights;2021-01